Pharmacogenetics of low dose clonidine in irritable bowel syndrome

Neurogastroenterology and Motility

Volumn 21, Issue 4, 2009, Pages 399-410

  Camilleri, M ^a,b   Busciglio, I ^a   Carlson, P ^a   McKinzie, S ^a   Burton, D ^a   Baxter, K ^a   Ryks, M ^a   Zinsmeister, A R ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adrenergic; G protein; GN 3; Receptor; Serotonergic; SLC6A4

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; CLONIDINE; EXCITATORY AMINO ACID TRANSPORTER 4; SEROTONIN TRANSPORTER;

ADULT; ALPHA 2A ADRENERGIC RECEPTOR GENE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IRRITABLE COLON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; RECTAL COMPLIANCE; RECTUM; RECTUM SENSATION THRESHOLD; SATIETY; SENSORIMOTOR FUNCTION; SEROTONIN TRANSPORTER GENE; STOMACH VOLUME;

ADRENERGIC ALPHA-AGONISTS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 62449290346     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01263.x     Document Type: Article

References (39)

1. Weems WA, Szurszewski JH. Modulation of colonic motility by peripheral neural inputs to neurons of the inferior mesenteric ganglion. Gastroenterology 1977 73 : 273 8.
2. Chang EB, Bergenstal RM, Field M. Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest 1985 75 : 1666 70.
3. O'Mahony S, Dinan TG, Keeling PW, Chua AS. Central serotonergic and noradrenergic receptors in functional dyspepsia. World J Gastroenterol 2006 12 : 2681 7.
4. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000 95 : 2698 709.
5. Nakagawa I, Omote K, Kitahata LM, Collins JG, Murata K. Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems. Anesthesiology 1990 73 : 474 8.
6. Camilleri M. Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol Motil 2005 17 : 311 6.
7. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997 273 : G997 1006.
8. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999 116 : 573 85.
9. Viramontes BE, Malcolm A, Camilleri M et al. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol 2001 281 : G1468 76.
10. Camilleri M, Kim DY, McKinzie S et al. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2003 1 : 111 21.
11. Camilleri M, Atanasova E, Carlson PJ et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002 123 : 425 32.
12. Li Y, Nie Y, Xie J et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci 2007 52 : 2942 9.
13. Grudell ABM, Camilleri M, Carlson P et al. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil 2008 20 : 213 9.
14. Camilleri M, Busciglio I, Carlson P et al. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol 2008 295 : 219 25.
15. Camilleri M, McKinzie S, Busciglio I et al. Prospective study of motor, sensory, psychologic and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008 6 : 772 81.
16. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990 65 : 1456 79.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 70.
18. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973 9 : 13 28.
19. Osman A, Breitenstein JL, Barrios FX, Gutierrez PM, Kopper BA. The fear of pain questionnaire III: further reliability and validity with nonclinical samples. J Behav Med 2002 25 : 155 73.
20. Taylor S, Cox BJ. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord 1998 12 : 463 83.
21. Chial HJ, Camilleri C, Delgado-Aros S et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil 2002 14 : 249 53.
22. Bouras EP, Delgado-Aros S, Camilleri M et al. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut 2002 51 : 781 6.
23. Cremonini F, Houghton LA, Camilleri M et al. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil 2005 17 : 810 20.
24. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998 274 : G584 90.
25. Floyd BNI, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based, and manual linear interpolation models. Neurogastroenterol Motil 2008 20 : 330 5.
26. Kim HJ, Camilleri M, Carlson PJ et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004 53 : 829 37.
27. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distribution. J Am Statistical Assoc 1989 84 : 1065 73.
28. Andrews CN, Bharucha AE, Camilleri M et al. Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil 2007 19 : 716 23.
29. Lavand'homme P, De Kock M. The use of intraoperative epidural or spinal analgesia modulates postoperative hyperalgesia and reduces residual pain after major abdominal surgery. Acta Anaesthesiol Belg 2006 57 : 373 9.
30. De Kock M, Lavand'homme P, Waterloos H. The short-lasting analgesia and long-term antihyperalgesic effect of intrathecal clonidine in patients undergoing colonic surgery. Anesth Analg 2005 101 : 566 72.
31. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut 2001 48 : 125 31.
32. Baumgart D, Naber C, Haude M et al. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res 1999 85 : 965 9.
33. Rosskopf D, Manthey I, Habich C et al. Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003 371 : 223 32.
34. Siffert W, Rosskopf D, Siffert G et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998 18 : 45 8.
35. Rosskopf D, Koch K, Habich C et al. Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal 2003 15 : 479 88.
36. Ruiz-Velasco V, Ikeda SR. A splice variant of the G protein beta 3-subunit implicated in disease states does not modulate ion channels. Physiol Genomics 2003 13 : 85 95.
37. Avissar S, Schreiber G. Ziskind-Somerfeld Research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatr 1992 31 : 435 59.
38. Siffert W. Cardiovascular pharmacogenetics: on the way toward individually tailored drug therapy. Kidney Int 2003 84 : S168 71.
39. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol 2003 284 : G130 7.